| |
| |
|
| Insider
Information: |
Kovner Bruce |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
5,440,673 |
|
|
Indirect Shares
|
20,072,571 |
|
|
| Direct
Value |
$686,527,957 |
|
|
|
Indirect Value
|
$3,966,620,980 |
|
|
| Total
Shares |
25,513,244 |
|
|
| Total
Value |
$4,653,148,937 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 28.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Madrigal Pharmaceuticals Inc |
MDGL |
Director, 10% Owner |
2015-12-08 |
3,092,677 |
2015-12-08 |
18,019,580 |
Premium* |
|
|
Kala Pharmaceuticals, Inc. |
KALA |
10% Owner |
2017-07-20 |
763,755 |
2017-07-20 |
0 |
Premium* |
|
|
Molecular Templates, Inc. |
MTEM |
Director |
2018-12-26 |
1,584,241 |
2019-11-21 |
2,052,991 |
Premium* |
|
|
Strongbridge Biopharma Plc |
SBBP |
10% Owner |
2021-10-05 |
0 |
2018-07-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2007-02-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
87,954 |
|
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2007-02-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,071,070 |
|
- |
|
| MTEM |
Molecular Templates, Inc. |
Director |
– • – |
2017-08-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,013,787 |
|
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2006-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,857 |
87,954 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2007-02-09 |
4 |
A |
$0.00 |
$0 |
I/I |
1,690,646 |
7,761,716 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2007-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
23,648 |
111,602 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2008-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,398 |
907,467 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2009-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
16,806 |
950,673 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2010-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,444 |
1,784,850 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2011-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,858 |
4,765,124 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2011-12-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
500,000 |
4,769,685 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2011-12-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
500,000 |
125,000 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2012-06-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,900,000 |
475,000 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2012-06-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,900,000 |
4,916,048 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2012-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,140 |
4,925,188 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2013-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
6,180,330 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2014-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,194 |
3,060,860 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2015-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
2,279,146 |
2,279,146 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2015-06-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,279,146) |
120,854 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2015-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
31,817 |
3,092,677 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2015-09-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,120,854) |
11,399,464 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2015-09-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,120,854 |
4,000,000 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
10% Owner |
– – • |
2017-07-20 |
4/A |
A |
$0.00 |
$0 |
D/D |
548,755 |
548,755 |
0 |
- |
|
| SBBP |
Strongbridge Biopharma Pl... |
10% Owner |
– – • |
2021-10-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,060,682) |
0 |
0 |
- |
|
| MDGL |
Madrigal Pharmaceuticals ... |
Director |
– • • |
2015-12-07 |
4 |
S |
$0.41 |
$41 |
I/I |
(100) |
836,985 |
0 |
- |
|
119 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
